ALK mutation did not affect the prognosis of NSCLC patients with BM, and the expressions of hsa_circ_0072309, miR‐100, and ACKR3 mRNAs and ACKR3 protein in serum. Here, ACKR3 is linked to non-small cell lung carcinoma.